Infant Mortality in Saskatchewan: Evidence to Inform Public Health Practice
Attributes to meet: PDF: Download File, Reports
Download File: condition met
Report, 2009
This document was prepared to describe the relationship between modifiable risk factors and infant mortality. It is meant to provide guidance, strategies, and support to help expand or develop programs that may contribute to the reduction of infant mortality in Saskatchewan. It includes a review of the literature regarding prevalent risk factors associated with infant mortality, as well as identifying promising practices related to those modifiable risk factors.
Related products
-

Abusive Head Trauma (Shaken Baby Syndrome)
Fact Sheet, Revised 2019
Explains what abusive head trauma is, including how and why it happens, the long-term effects, and how it can be prevented. Aimed at health professionals and service providers who work with families. For information aimed at caregivers, see When Your Baby Can’t Stop Crying (resource 4-902).
SKU: 4-900 -

Hope for the Future: Having a Healthy Pregnancy While Living with HIV
Video, 2013
This DVD shares information about HIV, pregnancy, and parenting, with the goal of showing that healthy pregnancies and healthy babies are possible for pregnant women living with HIV in Saskatchewan. The knowledge and experiences of people living with HIV and those who work in this area are shared. The DVD was created as a resource for health and allied health professionals and for people living with HIV in Saskatchewan.
SKU: 7-000 -

Neonatal Abstinence Syndrome
Fact Sheet, 2020
Neonatal abstinence syndrome (NAS) is a condition whereby infants who are exposed to particular substances in the womb experience a variety of withdrawal symptoms shortly after they are born. This fact sheet shares information about the signs and symptoms of NAS, treatment, at-home care recommendations, and potential long-term outcomes.
SKU: 2-906 -

Neonatal Abstinence Syndrome Literature Review
Report, 2020
Neonatal abstinence syndrome (NAS) is a condition whereby some infants exposed to particular substances in utero experience a variety of postnatal withdrawal symptoms shortly after birth. Increased rates of NAS have been reported in Canada over the past decade. This review provides information about the development and effects of NAS, modes of assessment, treatment options (both pharmacological and non-pharmacological), care guidelines for parents and caregivers, and primary prevention strategies.
SKU: 2-905

